137 related articles for article (PubMed ID: 3523534)
1. The value of dexamethasone when added to combination drug therapy in the prevention of cisplatin-induced nausea and vomiting, evaluated by time-lapse video technology.
Rhinehart SN; Dugan WM; Parashos PJ; Triplett WC; Minnick DJ; Fry MW
Prog Clin Biol Res; 1986; 216():407-16. PubMed ID: 3523534
[No Abstract] [Full Text] [Related]
2. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
Kris MG; Gralla RJ; Clark RA; Tyson LB; Fiore JJ; Kelsen DP; Groshen S
Cancer Treat Rep; 1985 Nov; 69(11):1257-62. PubMed ID: 3912039
[TBL] [Abstract][Full Text] [Related]
3. Immediate termination of intractable vomiting induced by cisplatin combination chemotherapy using an intensive five-drug antiemetic regimen.
Plezia PM; Alberts DS; Kessler J; Aapro MS; Graham V; Surwit EA
Cancer Treat Rep; 1984 Dec; 68(12):1493-5. PubMed ID: 6542448
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of metoclopramide, dexamethasone, diphenhydramine and lorazepam in prevention of nausea and vomiting in cisplatin-treated male patients.
Roila F; Basurto C; Bracarda S; Picciafuoco M; Ballatori E; Del Favero A; Tonato M
Oncology; 1990; 47(5):415-7. PubMed ID: 2216296
[TBL] [Abstract][Full Text] [Related]
5. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.
Sarcev T; Secen N; Povazan Dj; Sabo A; Popovic J; Bursac D; Kakas M; Zaric B; Milovancev A
J BUON; 2007; 12(2):245-52. PubMed ID: 17600880
[TBL] [Abstract][Full Text] [Related]
6. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
[TBL] [Abstract][Full Text] [Related]
7. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
8. [Randomized controlled study of high-dose metoclopramide and dexamethasone in the prevention of CDDP-induced emesis].
Umehara H; Sawamura N; Takahashi S; Kusano H; Yokoyama S; Suemasu K
Gan To Kagaku Ryoho; 1986 May; 13(5):1996-8. PubMed ID: 3010886
[No Abstract] [Full Text] [Related]
9. Ondansetron: a specific serotonin antagonist for the prevention of chemotherapy-induced vomiting.
Kris MG
Important Adv Oncol; 1994; ():165-77. PubMed ID: 8206488
[No Abstract] [Full Text] [Related]
10. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
[TBL] [Abstract][Full Text] [Related]
11. Combination antiemetics for cisplatin chemotherapy.
Sridhar KS; Donnelly E
Cancer; 1988 Apr; 61(8):1508-17. PubMed ID: 3280112
[TBL] [Abstract][Full Text] [Related]
12. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M
Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of nausea and vomiting induced by a 24-hour i.v. infusion of cisplatin].
Nagai H; Suga S; Horiuchi Y; Kyokane K; Miwa Y; Aoki Y; Yasue K; Noro T; Kamikawa R; Ninomiya E
Gan No Rinsho; 1990 Jun; 36(7):791-6. PubMed ID: 2113110
[TBL] [Abstract][Full Text] [Related]
14. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of antiemetic effect of clonazepam, metoclopramide, dexamethasone and diphenhydramine for prevention of cisplatin-induced vomiting].
Hatae M; Nakamura Y; Mitsuo M; Sakurai K; Asano H; Onishi Y; Hokanishi H
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1495-9. PubMed ID: 2389945
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone in the treatment of nausea and vomiting from cancer chemotherapy.
Winokur SH; Baker JJ; Lokey JL; Price NA; Bowen J
J Med Assoc Ga; 1981 Apr; 70(4):263-4. PubMed ID: 7012258
[No Abstract] [Full Text] [Related]
17. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
[TBL] [Abstract][Full Text] [Related]
18. [Metoclopramide in the prevention of nausea and vomiting caused by cytostatics].
Swierz J; Krzakowski M; Szutkowski Z; Nowakowski W
Wiad Lek; 1985 May; 38(10):715-8. PubMed ID: 3901527
[No Abstract] [Full Text] [Related]
19. Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. The Nordic Antiemetic Trial Group.
Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Andersson H; Hansen O; Sørensen BT; Räisänen I
Anticancer Drugs; 1995 Feb; 6 Suppl 1():31-6. PubMed ID: 7749168
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
